The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

EU regulator supports a label expansion of Novo Nordisk’s diabetes drug to reflect its potential to lower the risk of ...

A DeKalb County police officer suffering from suffering from a rare kidney disease is in a race against time. Here's how you ...

Apparently, it takes three to bring Boehringer Ingelheim and Eli Lilly’s joint “It Takes 2” initiative to the annual ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...

Chronic kidney disease (CKD) affects millions of people worldwide and can lead to serious health problems if left unchecked.

Our bodies have several vital organs that quietly toil away to keep us functioning properly. Among these are the kidneys, two fist-sized organs that sit on either side of the spine below the ribs.

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...